This Amendment No. 1 (this
Amendment
) to Schedule 13D (as amended to date, the
Schedule 13D
) is being filed by Cassa depositi e prestiti S.p.A. (the
Reporting Person
or
CDP
). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings
ascribed to them in the Schedule 13D. Except as otherwise specifically amended in this Amendment, items in the Schedule 13D remain unchanged.
ITEM 2.
|
IDENTITY AND BACKGROUND.
|
Item 2 (a) (c).
To the best of
CDPs knowledge as of the date hereof, set forth in Schedule I to this Amendment and incorporated herein by reference is the following information with respect to each director and executive officer of CDP:
|
(iii)
|
present principal occupation or employment and the name, principal business and address of any corporation or
other organization in which such employment is conducted; and
|
All other information contained in Item 2 of the Schedule 13D remains unchanged.
ITEM 3.
|
SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
|
CDP used approximately 960,983,567 (including brokerage commissions) of its working capital in the aggregate to purchase the Ordinary Shares reported in
this Schedule 13D.
ITEM 5.
|
INTEREST IN SECURITIES OF THE ISSUER.
|
Item 5 (a) (b)
As of the date of this report,
CDP beneficially owns 1,322,250,000 Ordinary Shares, representing approximately 8.7% of the Issuers Ordinary Shares based upon 15,203,122,583 Ordinary Shares outstanding, which is the total number of Ordinary Shares outstanding as of
September 30, 2018 as reported in the Issuers Report of Foreign Private Issuer filed on Form
6-K
with the Securities and Exchange Commission on November 28, 2018.
With respect to the persons referenced in Item 2 above, to the best of CDPs knowledge, as of the date hereof, no such person beneficially owns
Ordinary Shares of the Issuer.
(c)
Except for the
transactions described in the Schedule 13D, including those set forth on Schedule II, during the past 60 days there have been no other transactions in the securities of the Issuer effected by CDP or, to the best of CDPs knowledge,
the persons or entities referenced in Item 2 of the Schedule 13D.
All other information contained in Item 5 of the Schedule 13D remains unchanged.